---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-042071"
form_type: "8-K"
ticker: "OCEA"
cik: "0001869974"
company_name: "Ocean Biomedical, Inc."
filed_at: "2024-10-22T23:59:59+00:00"
generated_at: "2026-05-30T11:50:20.240209+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Ocean Biomedical receives Nasdaq delisting determination for missing filing deadlines

## Summary
- Nasdaq notified company on Oct 16, 2024 that it failed to file Form 10-K for 2023 and Forms 10-Q for Q1 and Q2 2024.
- Exception granted until Oct 14, 2024 was not met; company has not filed the required reports.
- Company will appeal the Staff determination to a Nasdaq Hearings Panel under Rule 5800 Series.
- Ticker OCEA and OCEAW remain listed pending appeal; outcome uncertain.

## SEC filing metadata
- accession: 0001493152-24-042071
- form_type: 8-K
- ticker: OCEA
- cik: 0001869974
- company_name: Ocean Biomedical, Inc.
- filed_at: 2024-10-22T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1869974/000149315224042071/0001493152-24-042071-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1869974/000149315224042071/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-042071
- JSON: https://secwatch.observer/filing/0001493152-24-042071.json
- Plain text: https://secwatch.observer/filing/0001493152-24-042071.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.